Market closed
Zoetis/$ZTS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Zoetis
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Ticker
$ZTS
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
14,100
Website
Zoetis Metrics
BasicAdvanced
$74B
Market cap
31.00
P/E ratio
$5.32
EPS
0.90
Beta
$1.73
Dividend rate
1.21%
Dividend yield
Price and volume
Market cap
$74B
Beta
0.9
52-week high
$200.53
52-week low
$144.80
Average daily volume
2.7M
Dividend rate
$1.73
Financial strength
Current ratio
3.691
Quick ratio
1.836
Long term debt to equity
129.442
Total debt to equity
129.442
Dividend payout ratio (TTM)
31.44%
Interest coverage (TTM)
14.33%
Management effectiveness
Return on assets (TTM)
14.66%
Return on equity (TTM)
47.30%
Valuation
Price to earnings (TTM)
30.999
Price to revenue (TTM)
8.219
Price to book
14.22
Price to tangible book (TTM)
57.08
Price to free cash flow (TTM)
32.589
Dividend yield (TTM)
1.05%
Forward dividend yield
1.21%
Growth
Revenue change (TTM)
9.33%
Earnings per share change (TTM)
8.38%
3-year revenue growth (CAGR)
6.32%
3-year earnings per share growth (CAGR)
8.62%
3-year dividend per share growth (CAGR)
20.71%
What the Analysts think about Zoetis
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Zoetis stock.
Zoetis Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Zoetis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Zoetis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Jan
21
Zoetis
Dividend·Ex-dividend
Mar
4
Zoetis
Dividend·Payment
$0.50
Per share
FAQs
What’s the current market cap for Zoetis stock?
Zoetis (ZTS) has a market cap of $74B as of December 22, 2024.
What is the P/E ratio for Zoetis stock?
The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 31 as of December 22, 2024.
Does Zoetis stock pay dividends?
Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is $1.728 and the yield is 1.21%. Zoetis has a payout ratio of 31.44% on a trailing twelve-month basis.
When is the next Zoetis dividend payment date?
The next Zoetis (ZTS) dividend payment is scheduled for March 04, 2025.
What is the beta indicator for Zoetis?
Zoetis (ZTS) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.